Cargando…
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844379/ https://www.ncbi.nlm.nih.gov/pubmed/31687859 http://dx.doi.org/10.1080/14756366.2019.1685510 |
_version_ | 1783468423941980160 |
---|---|
author | Aspatwar, Ashok Parvathaneni, Nanda Kumar Barker, Harlan Anduran, Emilie Supuran, Claudiu T. Dubois, Ludwig Lambin, Philippe Parkkila, Seppo Winum, Jean-Yves |
author_facet | Aspatwar, Ashok Parvathaneni, Nanda Kumar Barker, Harlan Anduran, Emilie Supuran, Claudiu T. Dubois, Ludwig Lambin, Philippe Parkkila, Seppo Winum, Jean-Yves |
author_sort | Aspatwar, Ashok |
collection | PubMed |
description | With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated the toxicity of these compounds using zebrafish larvae. Among the three compounds, derivative 4 showed efficient inhibition against hCA II (KI = 58.6 nM). Compound 10 showed moderate inhibition against hCA II (KI = 199.2 nM) and hCA IX (KI = 147.3 nM), whereas it inhibited hCA I less weakly at micromolar concentrations (KI = 6428.4 nM). All other inhibition constants for these compounds were in the submicromolar range. The toxicity evaluation studies showed no adverse effects on the zebrafish larvae. Our study suggests that these compounds are suitable for further preclinical characterisation as potential inhibitors of hCA I, II and IX. |
format | Online Article Text |
id | pubmed-6844379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-68443792019-11-18 Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series Aspatwar, Ashok Parvathaneni, Nanda Kumar Barker, Harlan Anduran, Emilie Supuran, Claudiu T. Dubois, Ludwig Lambin, Philippe Parkkila, Seppo Winum, Jean-Yves J Enzyme Inhib Med Chem Research Paper With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated the toxicity of these compounds using zebrafish larvae. Among the three compounds, derivative 4 showed efficient inhibition against hCA II (KI = 58.6 nM). Compound 10 showed moderate inhibition against hCA II (KI = 199.2 nM) and hCA IX (KI = 147.3 nM), whereas it inhibited hCA I less weakly at micromolar concentrations (KI = 6428.4 nM). All other inhibition constants for these compounds were in the submicromolar range. The toxicity evaluation studies showed no adverse effects on the zebrafish larvae. Our study suggests that these compounds are suitable for further preclinical characterisation as potential inhibitors of hCA I, II and IX. Taylor & Francis 2019-11-05 /pmc/articles/PMC6844379/ /pubmed/31687859 http://dx.doi.org/10.1080/14756366.2019.1685510 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Aspatwar, Ashok Parvathaneni, Nanda Kumar Barker, Harlan Anduran, Emilie Supuran, Claudiu T. Dubois, Ludwig Lambin, Philippe Parkkila, Seppo Winum, Jean-Yves Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title | Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title_full | Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title_fullStr | Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title_full_unstemmed | Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title_short | Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series |
title_sort | design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases i, ii and ix inhibitors in 5-nitroimidazole series |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844379/ https://www.ncbi.nlm.nih.gov/pubmed/31687859 http://dx.doi.org/10.1080/14756366.2019.1685510 |
work_keys_str_mv | AT aspatwarashok designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT parvathaneninandakumar designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT barkerharlan designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT anduranemilie designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT supuranclaudiut designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT duboisludwig designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT lambinphilippe designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT parkkilaseppo designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries AT winumjeanyves designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries |